Women’s Health Investment Outlook: 6% of Funding for Nearly 50% of the Population – Not Just a Gap, but Untapped White Space

The report reveals that women's health receives only 6% of private healthcare investment, with 90% of that capital concentrated in reproductive health, maternal care, and women's cancers. It introduces the Women's Health Investment Index to map these flows and identifies six prime investment areas, including cancer therapeutics and virtual healthcare. The document argues that addressing this 'white space'—particularly high-burden conditions like cardiovascular disease and menopause—represents a massive commercial opportunity, potentially unlocking over $100 billion in the US market alone by 2030.

• Private healthcare investment in women's health is severely disproportionate to the population it serves, capturing only 6% of total private healthcare funding, while companies exclusively focused on women's health receive less than 1%.
• Investment is heavily concentrated in three areas—reproductive health, maternal care, and women's cancers—which account for approximately 80% of funding events and 90% of total capital between 2020 and 2025.
• The women's health market is characterized by a 'leaky pipeline' where 50% of private investment in women's health-specific companies is concentrated at the pre-seed or seed stages, compared to 32% in the broader healthcare sector.
• There is a significant misalignment between funding and disease burden; high-prevalence conditions such as endometriosis, menopause, PCOS, and menstrual health represent less than 2% of identified women's health funding.
• Addressing just four therapeutic areas for women in the United States—menopause, osteoporosis, Alzheimer’s disease, and cardiovascular disease—could unlock a market opportunity exceeding $100 billion by 2030.
• The in vitro fertilization (IVF) market serves as a proof of scale, having evolved into a global industry estimated at $13 billion in 2024, driven by scientific advancement, cultural shifts, and expanded reimbursement.
• The report identifies six prime investment areas: women's cancer therapeutics, virtual women's healthcare and benefits management, remote maternal health monitoring, women-focused mental health platforms, women-first longevity and wellness concierge services, and wearable devices for metabolic health.
• Large healthcare incumbents are under-engaged in the sector; only about one-quarter of the top 100 global healthcare companies have a dedicated women's health business unit or active R&D program for women's health indications.
• Geographic investment is heavily skewed toward North America and Europe, leaving low- and middle-income countries (LMICs) under-represented despite their high disease burden.

APA

World Economic Forum (2026). Women’s Health Investment Outlook: 6% of Funding for Nearly 50% of the Population – Not Just a Gap, but Untapped White Space. https://reports.weforum.org/docs/WEF_Womens_Health_Investment_Outlook_2026.pdf

Chicago

World Economic Forum. Women’s Health Investment Outlook: 6% of Funding for Nearly 50% of the Population – Not Just a Gap, but Untapped White Space. 2026. https://reports.weforum.org/docs/WEF_Womens_Health_Investment_Outlook_2026.pdf.

Wikipedia

{{cite report |author=World Economic Forum |title=Women’s Health Investment Outlook: 6% of Funding for Nearly 50% of the Population – Not Just a Gap, but Untapped White Space |date=January 2026 |url=https://reports.weforum.org/docs/WEF_Womens_Health_Investment_Outlook_2026.pdf |access-date=23 October 2026 |via=Climate Insights Directory}}

BibTeX

@techreport{worldeconomicforum2026womens, author = {{World Economic Forum}}, title = {{Women’s Health Investment Outlook: 6\% of Funding for Nearly 50\% of the Population – Not Just a Gap, but Untapped White Space}}, institution = {World Economic Forum}, year = {2026}, month = jan, url = {https://reports.weforum.org/docs/WEF_Womens_Health_Investment_Outlook_2026.pdf}, urldate = {2026-10-23}, note = {Indexed by Climate Insights Directory} }